The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,732.50
Ask: 1,733.00
Change: 5.00 (0.29%)
Spread: 0.50 (0.029%)
Open: 1,733.00
High: 1,739.50
Low: 1,724.50
Prev. Close: 1,728.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 1-GSK shuts U.S. plant due to bacteria, no supply disruption seen

Wed, 12th Aug 2015 07:43

(Updates with product details, company comment on supplies)

By Karen Brooks and Ben Hirschler

Aug 12 (Reuters) - Drugmaker GlaxoSmithKline temporarilyclosed a North Carolina factory on Tuesday after testing at acooling tower found bacteria that causes deadly Legionnaire'sdisease.

The Legionella bacteria were discovered during routineinspections at the site in Zebulon, N.C., the company said.

The shutdown is not expected to disrupt supplies ofmedicines made at the factory, which include GSK's $7billion-a-year inhaled respiratory drug Advair. Advair is alsomade at two other sites in Ware, England, and Evreux, France.

GSK said the shutdown was a precautionary measure and theZebulon site would reopen when the situation was remedied. Thetower is a stand-alone structure that does not come in contactwith any products.

"The cooling towers will be cleaned and retested before thesite goes back into operation. GSK is taking these precautionsto ensure the health and safety of our employees, as well as thesafety and integrity of our products," the group said in astatement.

Spokeswoman Jenni Brewer Ligday said 600 workers were senthome or told not to come in while the towers were being cleaned.

City and state officials said the discovery did not warranta public health alert and that no threat was posed to citydrinking water, according to a report in the Charlotte News andObserver newspaper.

The Zebulon plant manufactures around 30 different GSK drugsin all, including malaria drug Malarone, HIV treatment Combivirand Requip for Parkinson's disease, but its biggest product lineis Advair, for asthma and chronic lung disease.

GSK is also planning to produce its next-generation drypowder inhaled respiratory drugs, such as Breo and Anoro, atZebulon, although for the moment these are only being made inWare.

Legionella bacteria are found naturally in warm water andthrive in environments such as hot tubs, cooling towers, watertanks, large plumbing systems and fountains, according to theU.S. Centers for Disease Control and Prevention.

Legionnaire's disease, a severe kind of pneumonia, iscontracted by breathing in mist containing the bacteria. It isnot contagious, according to the CDC.

Last week, New York City's Department of Health ordered theinspection and cleaning of all cooling towers in the city inresponse to an outbreak of Legionnaire's' disease that hasclaimed 12 lives. (Reporting by Karen Brooks in Austin, Texas; Editing by EricWalsh and Susan Thomas)

More News
12 Feb 2024 08:35

TOP NEWS: GSK's bepirovirsen receives US FDA fast track designation

(Alliance News) - GSK PLC on Monday said that the US health watchdog granted fast track designation for its bepirovirsen treatment for chronic hepatitis B.

Read more
12 Feb 2024 07:50

LONDON BRIEFING: Tritax Big Box, UK Commercial Property agree merger

(Alliance News) - Equities in London are called to open higher on Monday, with inflation readings from the US and UK on the horizon, which could drive equity market sentiment during the remainder of the week.

Read more
12 Feb 2024 07:21

GSK gets FDA fast track for chronic hepatitis B treatment

(Sharecast News) - GSK announced on Monday that bepirovirsen, an investigational antisense oligonucleotide (ASO) aimed at treating chronic hepatitis B (CHB), had been granted fast track designation by the US Food and Drug Administration (FDA).

Read more
9 Feb 2024 09:15

LONDON BROKER RATINGS: Deutsche Bank cuts AstraZeneca to 'sell'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
6 Feb 2024 08:51

TOP NEWS: GSK reports positive news on trio of high profile products

(Alliance News) - GSK PLC on Tuesday delivered a triple dose of positive updates on some of its leading products, Arexvy, Shingrix and Blencep.

Read more
6 Feb 2024 07:47

LONDON BRIEFING: BP promises buyback despite drop in profit

(Alliance News) - Stocks in London are called to open higher, ahead of a slew of construction purchasing managers' index readings from the eurozone, the UK and Germany.

Read more
6 Feb 2024 07:23

GSK reports positive myeloma trial results, progresses vaccine applications

(Sharecast News) - GSK reported progress in its trial of a myeloma treatment on Tuesday, as well as regulatory progress around its shingles vaccine in China and its RSV vaccine in the United States.

Read more
1 Feb 2024 09:27

TOP NEWS: GSK maintains "vigorous" defence after settling Zantac case

(Alliance News) - GSK PLC on Thursday insisted upon its scientific integrity, after reaching another settlement in ongoing litigation over alleged links between its heartburn drug and cancer.

Read more
1 Feb 2024 09:11

GSK settles Zantac case in California without admitting liability

(Sharecast News) - GSK announced on Thursday that it had reached a confidential settlement to effectively resolve the legal case over Zantac filed in a California state court.

Read more
1 Feb 2024 09:03

LONDON BROKER RATINGS: Barclays cuts Next; JPMorgan raises easyJet

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

Read more
1 Feb 2024 07:42

LONDON BRIEFING: Shell profit falls; announces USD3.5 billion buyback

(Alliance News) - Stocks in London are set to follow New York into the red, after the US Federal Reserve quashed hopes of a March cut to interest rates and ahead of the Bank of England interest rate decision.

Read more
31 Jan 2024 17:05

LONDON MARKET CLOSE: Stocks mixed hours before expected US Fed hold

(Alliance News) - Stock prices in London closed mixed on Wednesday in a trade-thinned day ahead of the US Federal Reserve interest rate decision this evening.

Read more
31 Jan 2024 15:49

London close: Stocks mixed ahead of US Fed, BoE decisions

(Sharecast News) - London's financial markets finished with mixed performance on Wednesday, with investors closing their wallets ahead of rate announcements from both the US Federal Reserve and the Bank of England.

Read more
31 Jan 2024 12:05

LONDON MARKET MIDDAY: FTSE 100 flat ahead of Federal Reserve decision

(Alliance News) - The FTSE 100 in London was flat heading into Wednesday afternoon, as the US Federal Reserve's latest interest rate decision edges closer, keeping equity market enthusiasm to a minimum.

Read more
31 Jan 2024 09:13

TOP NEWS: GSK profit up on Arexvy boost in 2023 but total payout down

(Alliance News) - GSK PLC reported an increase in profit and revenue for 2023 as revenue for HIV medicine had stable growth, amid optimism in the company's outlook.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.